Home
MyCare - Patients: View your medical records securely online here.
Log in Learn More

Cardiology

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 14
Evaluation of long term treatment of a combination pill of clopidogrel and prilosec compared to clopidogrel alone
Dr. Thomas Stuver

Subjects requiring long term treatment of dual anti-platelet therapy are randomized either to new combination pill of clopidogrel and prilosec or...

Mosaic° ULTRATm Bioprosthesis Aortic Valve, Model 305U
Dr. Ronald Kirshner

Purpose: Subjects requiring replacement of aortic heart valve with the FDA approved Medtronic Mosaic® UltraTM bioprsthetic heart valve. 6 month f/u...

Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Dr. Thomas Stuver

Subjects with history of or current high blood pressure and known renal artery stenosis are randomized either to renal stent plus medical therapy...

Longitudinal Surveillance Study of the 4-SITE Lead/Header System
8/22/2014
Mark Hamer, MD

For patients who will receive, or currently have, an FDA approved Boston Scientific 4-SITE lead and pulse generator with a 4-SITE header...

Absorb Randomized Controlled Trial – A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions
8/22/2014
Thomas Stuver, MD

Compare treatment of lesions (narrowing) in the coronary arteries using bioresorbable stents versus metallic drug-eluting stents. Sponsor: Abbott...

Absorb IV is a prospective, randomized (1:1, Absorb BVS to XIENCE), single-blind, multi-center study
8/22/2014
Thomas Stuver, MD

Compare treatment of lesions (narrowing) in the coronary arteries using bioresorbable stents versus metallic drug-eluting stents. Absorb IV is a...

A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated hsCRP.
8/22/2014
Thomas Stuver, MD

Study of post-myocardial infarction (heart attack) drug to prevent future cardiovascular events using interleukin anti-body to reduce...

CAPTIVATE: CAPTure Information Via Automatic Threshold Evaluation; a Prospective, Non-Randomized, Multi-Center, IDE Clinical Study
8/22/2014
Thomas Stuver, MD

This study will evaluate the PaceSafe Right Ventricular Autothreshold (RVAT) and Left Ventricular Autothreshold (LVAT) features for patients...

« Previous 12 Next »